| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | prolactin receptor binding | 3.01e-08 | 7 | 110 | 4 | GO:0005148 | |
| GeneOntologyMolecularFunction | growth hormone receptor binding | 1.78e-07 | 10 | 110 | 4 | GO:0005131 | |
| GeneOntologyMolecularFunction | hormone receptor binding | 3.56e-05 | 34 | 110 | 4 | GO:0051427 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.94e-04 | 231 | 110 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TRIO DOCK9 ARHGEF12 MCF2 ARHGEF18 ARHGEF11 FARP2 ASAP2 SIPA1L2 ARHGAP19 | 4.94e-04 | 507 | 110 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TRIO DOCK9 ARHGEF12 MCF2 ARHGEF18 ARHGEF11 FARP2 ASAP2 SIPA1L2 ARHGAP19 | 4.94e-04 | 507 | 110 | 10 | GO:0030695 |
| GeneOntologyBiologicalProcess | positive regulation of steroid hormone biosynthetic process | 5.28e-07 | 13 | 110 | 4 | GO:0090031 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via STAT | 1.28e-06 | 65 | 110 | 6 | GO:1904894 | |
| GeneOntologyBiologicalProcess | protein localization to centrosome | 1.72e-06 | 38 | 110 | 5 | GO:0071539 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule organizing center | 1.96e-06 | 39 | 110 | 5 | GO:1905508 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone biosynthetic process | 2.79e-06 | 19 | 110 | 4 | GO:0046886 | |
| GeneOntologyBiologicalProcess | positive regulation of multicellular organism growth | 5.05e-06 | 47 | 110 | 5 | GO:0040018 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | BICD2 HAUS6 RIPOR2 ODAD1 CEP290 APC KIFC2 CEP350 FSIP2 SYNE2 ZW10 PIBF1 GOLGA2 HTT NIN | 6.52e-06 | 720 | 110 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of steroid hormone biosynthetic process | 7.49e-06 | 24 | 110 | 4 | GO:0090030 | |
| GeneOntologyBiologicalProcess | organelle assembly | DNHD1 HAUS6 MYH7 RIPOR2 RPGRIP1L ODAD1 LRSAM1 SPTBN2 CEP290 RB1CC1 KIFC2 FARP2 CEP350 FSIP2 SYNE2 CEP83 PIBF1 GOLGA2 HTT | 8.58e-06 | 1138 | 110 | 19 | GO:0070925 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 9.77e-06 | 257 | 110 | 9 | GO:0007163 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 1.05e-05 | 26 | 110 | 4 | GO:0060396 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone metabolic process | 1.05e-05 | 26 | 110 | 4 | GO:0032352 | |
| GeneOntologyBiologicalProcess | microtubule-based process | BICD2 DNHD1 HAUS6 RIPOR2 ODAD1 CEP290 ASH1L APC KIFC2 CEP350 FSIP2 CATSPER2 SYNE2 ZW10 PIBF1 GOLGA2 HTT NIN | 1.19e-05 | 1058 | 110 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 1.22e-05 | 27 | 110 | 4 | GO:0071378 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via JAK-STAT | 1.44e-05 | 58 | 110 | 5 | GO:0046427 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule cytoskeleton | 1.57e-05 | 59 | 110 | 5 | GO:0072698 | |
| GeneOntologyBiologicalProcess | protein localization to cytoskeleton | 2.16e-05 | 63 | 110 | 5 | GO:0044380 | |
| GeneOntologyBiologicalProcess | aspartate secretion | 2.82e-05 | 2 | 110 | 2 | GO:0061528 | |
| GeneOntologyBiologicalProcess | positive regulation of aspartate secretion | 2.82e-05 | 2 | 110 | 2 | GO:1904450 | |
| GeneOntologyBiologicalProcess | regulation of aspartate secretion | 2.82e-05 | 2 | 110 | 2 | GO:1904448 | |
| GeneOntologyBiologicalProcess | positive regulation of tyrosine phosphorylation of STAT protein | 3.37e-05 | 69 | 110 | 5 | GO:0042531 | |
| GeneOntologyBiologicalProcess | centrosome localization | 3.53e-05 | 35 | 110 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 3.95e-05 | 36 | 110 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | regulation of hormone biosynthetic process | 3.95e-05 | 36 | 110 | 4 | GO:0046885 | |
| GeneOntologyBiologicalProcess | cilium organization | DNHD1 RPGRIP1L ODAD1 CEP290 CEP350 FSIP2 CEP78 SYNE2 CEP83 PIBF1 HTT | 4.81e-05 | 476 | 110 | 11 | GO:0044782 |
| GeneOntologyBiologicalProcess | positive regulation of steroid biosynthetic process | 4.92e-05 | 38 | 110 | 4 | GO:0010893 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 5.05e-05 | 75 | 110 | 5 | GO:0048286 | |
| GeneOntologyBiologicalProcess | non-motile cilium assembly | 6.10e-05 | 78 | 110 | 5 | GO:1905515 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 6.58e-05 | 254 | 110 | 8 | GO:0000819 | |
| GeneOntologyBiologicalProcess | response to growth hormone | 6.66e-05 | 41 | 110 | 4 | GO:0060416 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid metabolic process | 7.33e-05 | 42 | 110 | 4 | GO:0045940 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | RIPOR2 TRIO ARHGEF12 MCF2 ARHGEF18 ARHGEF11 CSF1 SIPA1L2 ARHGAP19 | 7.43e-05 | 333 | 110 | 9 | GO:0051056 |
| GeneOntologyBiologicalProcess | regulation of tyrosine phosphorylation of STAT protein | 9.20e-05 | 85 | 110 | 5 | GO:0042509 | |
| GeneOntologyBiologicalProcess | regulation of response to nutrient levels | 1.05e-04 | 46 | 110 | 4 | GO:0032107 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 1.18e-04 | 143 | 110 | 6 | GO:1904892 | |
| GeneOntologyBiologicalProcess | tyrosine phosphorylation of STAT protein | 1.21e-04 | 90 | 110 | 5 | GO:0007260 | |
| GeneOntologyBiologicalProcess | cilium assembly | DNHD1 RPGRIP1L ODAD1 CEP290 CEP350 FSIP2 SYNE2 CEP83 PIBF1 HTT | 1.33e-04 | 444 | 110 | 10 | GO:0060271 |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 1.41e-04 | 93 | 110 | 5 | GO:0040014 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | RIPOR2 TRIO DOCK9 ARHGEF12 MCF2 ARHGEF18 ARHGEF11 FARP2 CSF1 SIPA1L2 ARHGAP19 | 1.43e-04 | 538 | 110 | 11 | GO:0007264 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 1.43e-04 | 212 | 110 | 7 | GO:0000070 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 1.60e-04 | 216 | 110 | 7 | GO:0097696 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | DNHD1 RIPOR2 RPGRIP1L ODAD1 CEP290 APC CEP350 FSIP2 SYNE2 CEP83 PIBF1 HTT | 2.41e-04 | 670 | 110 | 12 | GO:0120031 |
| GeneOntologyBiologicalProcess | response to food | 2.60e-04 | 58 | 110 | 4 | GO:0032094 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 2.60e-04 | 58 | 110 | 4 | GO:0032350 | |
| GeneOntologyBiologicalProcess | cell projection assembly | DNHD1 RIPOR2 RPGRIP1L ODAD1 CEP290 APC CEP350 FSIP2 SYNE2 CEP83 PIBF1 HTT | 2.95e-04 | 685 | 110 | 12 | GO:0030031 |
| GeneOntologyBiologicalProcess | microtubule anchoring | 3.12e-04 | 25 | 110 | 3 | GO:0034453 | |
| GeneOntologyBiologicalProcess | positive regulation of D-glucose transmembrane transport | 3.58e-04 | 63 | 110 | 4 | GO:0010828 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 3.76e-04 | 177 | 110 | 6 | GO:0030010 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 3.80e-04 | 249 | 110 | 7 | GO:0035264 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in mitosis | 5.03e-04 | 187 | 110 | 6 | GO:1902850 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 5.56e-04 | 125 | 110 | 5 | GO:0046425 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-methionine acetylation | 5.82e-04 | 7 | 110 | 2 | GO:0017196 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 6.47e-04 | 356 | 110 | 8 | GO:0098813 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 6.79e-04 | 198 | 110 | 6 | GO:0007259 | |
| GeneOntologyBiologicalProcess | corpus callosum development | 7.17e-04 | 33 | 110 | 3 | GO:0022038 | |
| GeneOntologyBiologicalProcess | corpus callosum morphogenesis | 7.73e-04 | 8 | 110 | 2 | GO:0021540 | |
| GeneOntologyBiologicalProcess | positive regulation of amino acid transport | 7.83e-04 | 34 | 110 | 3 | GO:0051957 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 8.66e-04 | 465 | 110 | 9 | GO:0007059 | |
| GeneOntologyBiologicalProcess | mammary duct terminal end bud growth | 9.90e-04 | 9 | 110 | 2 | GO:0060763 | |
| GeneOntologyBiologicalProcess | hormone biosynthetic process | 1.02e-03 | 83 | 110 | 4 | GO:0042446 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 1.21e-03 | 87 | 110 | 4 | GO:0033143 | |
| GeneOntologyCellularComponent | growth hormone receptor complex | 1.08e-08 | 6 | 110 | 4 | GO:0070195 | |
| GeneOntologyCellularComponent | bicellular tight junction | 6.79e-05 | 131 | 110 | 6 | GO:0005923 | |
| GeneOntologyCellularComponent | tight junction | 9.42e-05 | 139 | 110 | 6 | GO:0070160 | |
| GeneOntologyCellularComponent | apical junction complex | 1.90e-04 | 158 | 110 | 6 | GO:0043296 | |
| GeneOntologyCellularComponent | NatA complex | 2.72e-04 | 5 | 110 | 2 | GO:0031415 | |
| GeneOntologyCellularComponent | centriole | 3.00e-04 | 172 | 110 | 6 | GO:0005814 | |
| GeneOntologyCellularComponent | microtubule organizing center | BICD2 HAUS6 RPGRIP1L CEP290 APC KIFC2 CEP350 CEP78 CEP83 PIBF1 PIK3R5 CCDC116 HTT NIN | 3.31e-04 | 919 | 110 | 14 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | BICD2 HAUS6 RPGRIP1L CEP290 APC CEP350 CEP78 CEP83 PIBF1 PIK3R5 CCDC116 NIN | 7.40e-04 | 770 | 110 | 12 | GO:0005813 |
| GeneOntologyCellularComponent | ciliary transition fiber | 1.20e-03 | 10 | 110 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | N-terminal protein acetyltransferase complex | 1.20e-03 | 10 | 110 | 2 | GO:0031414 | |
| MousePheno | decreased pituitary gland weight | 1.37e-07 | 8 | 95 | 4 | MP:0008938 | |
| MousePheno | absent somatotrophs | 2.46e-07 | 9 | 95 | 4 | MP:0008330 | |
| MousePheno | absent lactotrophs | 2.46e-07 | 9 | 95 | 4 | MP:0008333 | |
| MousePheno | increased circulating ghrelin level | 9.50e-07 | 12 | 95 | 4 | MP:0011612 | |
| MousePheno | abnormal pituitary gland weight | 9.50e-07 | 12 | 95 | 4 | MP:0008937 | |
| MousePheno | abnormal circulating ghrelin level | 2.58e-06 | 15 | 95 | 4 | MP:0011611 | |
| MousePheno | decreased lactotroph cell number | 4.45e-06 | 17 | 95 | 4 | MP:0008332 | |
| MousePheno | abnormal lactotroph morphology | 7.17e-06 | 19 | 95 | 4 | MP:0008323 | |
| MousePheno | decreased somatotroph cell number | 1.10e-05 | 21 | 95 | 4 | MP:0008329 | |
| MousePheno | small adenohypophysis | 1.61e-05 | 23 | 95 | 4 | MP:0008321 | |
| MousePheno | abnormal somatotroph morphology | 1.92e-05 | 24 | 95 | 4 | MP:0008322 | |
| MousePheno | delayed sexual maturation | 1.96e-05 | 49 | 95 | 5 | MP:0001938 | |
| MousePheno | delayed vaginal opening | 3.62e-05 | 28 | 95 | 4 | MP:0002636 | |
| MousePheno | small pituitary gland | 4.79e-05 | 30 | 95 | 4 | MP:0005361 | |
| MousePheno | abnormal timing of vaginal opening | 5.47e-05 | 31 | 95 | 4 | MP:0020150 | |
| MousePheno | abnormal sexual maturation | 1.45e-04 | 74 | 95 | 5 | MP:0001937 | |
| MousePheno | abnormal pituitary gland size | 1.84e-04 | 42 | 95 | 4 | MP:0008936 | |
| MousePheno | abnormal cerebral hemisphere morphology | BICD2 FILIP1 MICAL1 RPGRIP1L TRIO TMEM94 CEP290 CCDC85C PEX11B THAP11 CSF1 WDFY3 HTT | 1.99e-04 | 599 | 95 | 13 | MP:0008540 |
| MousePheno | increased brown adipose tissue amount | 2.02e-04 | 43 | 95 | 4 | MP:0000005 | |
| MousePheno | thin epidermis stratum spinosum | 2.72e-04 | 4 | 95 | 2 | MP:0001238 | |
| MousePheno | absent subplate | 2.72e-04 | 4 | 95 | 2 | MP:0008443 | |
| MousePheno | abnormal forebrain morphology | BICD2 FILIP1 MICAL1 RPGRIP1L TRIO TMEM94 CEP290 APC CCDC85C PEX11B THAP11 GH1 GH2 CSF1 CSH1 CSH2 WDFY3 HTT | 2.82e-04 | 1072 | 95 | 18 | MP:0000783 |
| MousePheno | abnormal cerebellum morphology | BICD2 RPGRIP1L SPTBN2 CEP290 CCDC85C PEX11B MLC1 MTHFR GOLGA2 HTT | 3.05e-04 | 389 | 95 | 10 | MP:0000849 |
| MousePheno | abnormal neocortex morphology | 3.10e-04 | 48 | 95 | 4 | MP:0008547 | |
| MousePheno | abnormal secondary sex determination | 3.63e-04 | 90 | 95 | 5 | MP:0002212 | |
| MousePheno | abnormal adenohypophysis morphology | 4.02e-04 | 92 | 95 | 5 | MP:0004163 | |
| MousePheno | increased white adipose tissue amount | 4.22e-04 | 52 | 95 | 4 | MP:0000008 | |
| MousePheno | abnormal metencephalon morphology | BICD2 RPGRIP1L SPTBN2 CEP290 CCDC85C PEX11B MLC1 MTHFR GOLGA2 HTT | 5.58e-04 | 420 | 95 | 10 | MP:0000847 |
| MousePheno | disproportionate dwarf | 6.00e-04 | 57 | 95 | 4 | MP:0002427 | |
| Domain | SOMATOTROPIN_2 | 1.69e-08 | 6 | 110 | 4 | PS00338 | |
| Domain | Hormone_1 | 1.69e-08 | 6 | 110 | 4 | PF00103 | |
| Domain | SOMATOTROPIN_1 | 1.69e-08 | 6 | 110 | 4 | PS00266 | |
| Domain | Somatotropin | 3.93e-08 | 7 | 110 | 4 | IPR001400 | |
| Domain | Spectrin_repeat | 6.86e-07 | 29 | 110 | 5 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.15e-06 | 32 | 110 | 5 | IPR018159 | |
| Domain | SPEC | 1.15e-06 | 32 | 110 | 5 | SM00150 | |
| Domain | DH_1 | 1.88e-06 | 63 | 110 | 6 | PS00741 | |
| Domain | Somatotropin_CS | 1.97e-06 | 5 | 110 | 3 | IPR018116 | |
| Domain | RhoGEF | 2.96e-06 | 68 | 110 | 6 | SM00325 | |
| Domain | GDS_CDC24_CS | 3.17e-06 | 39 | 110 | 5 | IPR001331 | |
| Domain | RhoGEF | 3.51e-06 | 70 | 110 | 6 | PF00621 | |
| Domain | DH_2 | 3.51e-06 | 70 | 110 | 6 | PS50010 | |
| Domain | DH-domain | 3.82e-06 | 71 | 110 | 6 | IPR000219 | |
| Domain | - | 3.82e-06 | 71 | 110 | 6 | 1.20.900.10 | |
| Domain | ARM-like | 4.45e-06 | 270 | 110 | 10 | IPR011989 | |
| Domain | ARM-type_fold | RIPOR2 DOCK9 APC HEATR5A ITPR2 MROH1 XPO5 WDFY3 HTT TANGO6 SYMPK | 5.15e-06 | 339 | 110 | 11 | IPR016024 |
| Domain | - | 6.61e-06 | 222 | 110 | 9 | 1.25.10.10 | |
| Domain | Spectrin | 9.25e-06 | 23 | 110 | 4 | PF00435 | |
| Domain | NatA_aux_su | 3.44e-05 | 2 | 110 | 2 | IPR021183 | |
| Domain | DUF4525 | 3.44e-05 | 2 | 110 | 2 | IPR027833 | |
| Domain | NARP1 | 3.44e-05 | 2 | 110 | 2 | PF12569 | |
| Domain | DUF4525 | 3.44e-05 | 2 | 110 | 2 | PF15027 | |
| Domain | PH | TRIO DOCK9 SPTBN2 ARHGEF12 MCF2 ARHGEF18 ARHGEF11 FARP2 ASAP2 | 3.94e-05 | 278 | 110 | 9 | SM00233 |
| Domain | PH_DOMAIN | TRIO DOCK9 SPTBN2 ARHGEF12 MCF2 ARHGEF18 ARHGEF11 FARP2 ASAP2 | 4.05e-05 | 279 | 110 | 9 | PS50003 |
| Domain | PH_domain | TRIO DOCK9 SPTBN2 ARHGEF12 MCF2 ARHGEF18 ARHGEF11 FARP2 ASAP2 | 4.17e-05 | 280 | 110 | 9 | IPR001849 |
| Domain | PH_dom-like | TRIO DOCK9 SPTBN2 ARHGEF12 MCF2 ARHGEF18 ARHGEF11 FRMD4B FARP2 ASAP2 WDFY3 | 4.30e-05 | 426 | 110 | 11 | IPR011993 |
| Domain | 4_helix_cytokine-like_core | 7.54e-05 | 74 | 110 | 5 | IPR009079 | |
| Domain | RGS-like | 1.03e-04 | 3 | 110 | 2 | PF09128 | |
| Domain | GlyclTrfase_18 | 1.03e-04 | 3 | 110 | 2 | IPR026116 | |
| Domain | RGS-like_dom | 1.03e-04 | 3 | 110 | 2 | IPR015212 | |
| Domain | - | TRIO DOCK9 SPTBN2 ARHGEF12 MCF2 ARHGEF18 ARHGEF11 FRMD4B FARP2 ASAP2 | 1.05e-04 | 391 | 110 | 10 | 2.30.29.30 |
| Domain | 4_helix_cytokine_core | 2.30e-04 | 51 | 110 | 4 | IPR012351 | |
| Domain | PH | 4.15e-04 | 229 | 110 | 7 | PF00169 | |
| Domain | HEAT_REPEAT | 7.75e-04 | 70 | 110 | 4 | PS50077 | |
| Domain | HEAT | 2.84e-03 | 48 | 110 | 3 | PF02985 | |
| Domain | - | 3.19e-03 | 50 | 110 | 3 | 1.20.1250.10 | |
| Domain | HEAT | 4.85e-03 | 58 | 110 | 3 | IPR000357 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 9.27e-07 | 13 | 87 | 4 | MM14516 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 2.33e-06 | 16 | 87 | 4 | MM15710 | |
| Pathway | BIOCARTA_LONGEVITY_PATHWAY | 4.89e-06 | 19 | 87 | 4 | MM1513 | |
| Pathway | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | 6.08e-06 | 20 | 87 | 4 | MM15070 | |
| Pathway | PID_RHOA_REG_PATHWAY | 8.95e-06 | 46 | 87 | 5 | M68 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.65e-05 | 52 | 87 | 5 | MM14743 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 1.82e-05 | 26 | 87 | 4 | MM1345 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 2.71e-05 | 142 | 87 | 7 | MM15576 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 2.86e-05 | 29 | 87 | 4 | MM1522 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 3.07e-05 | 59 | 87 | 5 | M11215 | |
| Pathway | PID_CDC42_REG_PATHWAY | 3.28e-05 | 30 | 87 | 4 | M83 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 3.69e-05 | 149 | 87 | 7 | M41805 | |
| Pathway | BIOCARTA_GH_PATHWAY | 4.83e-05 | 33 | 87 | 4 | MM1404 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 6.21e-05 | 13 | 87 | 3 | M47731 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 7.04e-05 | 70 | 87 | 5 | MM14824 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | FILIP1 TRIO DOCK9 ARHGEF12 MCF2 ARHGEF18 ARHGEF11 FARP2 GOLGA2 PKN3 ARHGAP19 | 7.83e-05 | 439 | 87 | 11 | MM15595 |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 9.79e-05 | 15 | 87 | 3 | M552 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 1.04e-04 | 76 | 87 | 5 | M19832 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.11e-04 | 77 | 87 | 5 | MM15044 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.33e-04 | 80 | 87 | 5 | M800 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 1.77e-04 | 85 | 87 | 5 | MM14746 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.38e-04 | 339 | 87 | 9 | M39736 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.84e-04 | 94 | 87 | 5 | MM15598 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 3.14e-04 | 96 | 87 | 5 | MM15207 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 3.29e-04 | 97 | 87 | 5 | M9400 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 3.29e-04 | 97 | 87 | 5 | M27478 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 3.89e-04 | 155 | 87 | 6 | M17411 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 4.18e-04 | 24 | 87 | 3 | M519 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | FILIP1 TRIO DOCK9 ARHGEF12 MCF2 ARHGEF18 ARHGEF11 FARP2 PKN3 ARHGAP19 | 4.42e-04 | 450 | 87 | 10 | M27078 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | FILIP1 TRIO DOCK9 ARHGEF12 MCF2 ARHGEF18 ARHGEF11 FARP2 ZW10 GOLGA2 PKN3 ARHGAP19 | 6.13e-04 | 649 | 87 | 12 | MM15690 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 7.39e-04 | 175 | 87 | 6 | MM15599 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 7.75e-04 | 7 | 87 | 2 | M47646 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 8.62e-04 | 69 | 87 | 4 | MM15596 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.98e-04 | 326 | 87 | 8 | MM15917 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 9.10e-04 | 70 | 87 | 4 | M41806 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 9.10e-04 | 70 | 87 | 4 | MM15597 | |
| Pathway | REACTOME_PEPTIDE_HORMONE_METABOLISM | 9.10e-04 | 70 | 87 | 4 | MM14916 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 9.59e-04 | 184 | 87 | 6 | M41809 | |
| Pathway | WP_CILIOPATHIES | 9.59e-04 | 184 | 87 | 6 | M39880 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.12e-03 | 74 | 87 | 4 | M41807 | |
| Pathway | WP_JOUBERT_SYNDROME | 1.24e-03 | 76 | 87 | 4 | M39835 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 1.32e-03 | 9 | 87 | 2 | M26935 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY | 1.32e-03 | 9 | 87 | 2 | M47732 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 1.32e-03 | 9 | 87 | 2 | MM14548 | |
| Pathway | WP_ADIPOGENESIS_GENES | 1.57e-03 | 137 | 87 | 5 | MM15970 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.64e-03 | 10 | 87 | 2 | M47661 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 1.84e-03 | 142 | 87 | 5 | MM15431 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 2.00e-03 | 11 | 87 | 2 | MM15046 | |
| Pubmed | Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice. | 6.32e-12 | 7 | 111 | 5 | 26015548 | |
| Pubmed | 1.68e-11 | 8 | 111 | 5 | 27226307 | ||
| Pubmed | RPGRIP1L CCDC186 ARHGEF12 VPS16 GTPBP1 CEP350 CEP78 SYNE2 CEP83 GOLGA5 PIBF1 NIN | 3.22e-11 | 251 | 111 | 12 | 29778605 | |
| Pubmed | 9.83e-11 | 4 | 111 | 4 | 7169009 | ||
| Pubmed | Central growth hormone action regulates metabolism during pregnancy. | 4.90e-10 | 5 | 111 | 4 | 31479305 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 10767558 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 18006625 | ||
| Pubmed | Growth hormone prevents the development of autoimmune diabetes. | 4.90e-10 | 5 | 111 | 4 | 24218587 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 9546108 | ||
| Pubmed | Transgene transmission to progeny by oMt1a-oGH transgenic mice. | 4.90e-10 | 5 | 111 | 4 | 16201410 | |
| Pubmed | Genes that prolong life: relationships of growth hormone and growth to aging and life span. | 4.90e-10 | 5 | 111 | 4 | 11487592 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 11318985 | ||
| Pubmed | Identification of the glomerular podocyte as a target for growth hormone action. | 4.90e-10 | 5 | 111 | 4 | 17272398 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 20707609 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 1874564 | ||
| Pubmed | Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice. | 4.90e-10 | 5 | 111 | 4 | 32100023 | |
| Pubmed | Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies. | 4.90e-10 | 5 | 111 | 4 | 10810296 | |
| Pubmed | Somatotropin transgenic mice have reduced jejunal active glucose transport rates. | 4.90e-10 | 5 | 111 | 4 | 7965203 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 17347312 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 21852148 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 12175649 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 15070902 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 14726450 | ||
| Pubmed | UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences. | 4.90e-10 | 5 | 111 | 4 | 24758742 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 10076541 | ||
| Pubmed | Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads. | 4.90e-10 | 5 | 111 | 4 | 10594738 | |
| Pubmed | Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes. | 4.90e-10 | 5 | 111 | 4 | 23639351 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 21098290 | ||
| Pubmed | Age-related changes in body composition of bovine growth hormone transgenic mice. | 4.90e-10 | 5 | 111 | 4 | 18948397 | |
| Pubmed | Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. | 4.90e-10 | 5 | 111 | 4 | 8496314 | |
| Pubmed | Exploring endocrine GH pattern in mice using rank plot analysis and random blood samples. | 4.90e-10 | 5 | 111 | 4 | 21045135 | |
| Pubmed | Analysis of gender difference of cardiac risk biomarkers using hGH-transgenic mice. | 4.90e-10 | 5 | 111 | 4 | 16508206 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 15616010 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 19019400 | ||
| Pubmed | The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH? | 4.90e-10 | 5 | 111 | 4 | 32556100 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 1525063 | ||
| Pubmed | Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. | 4.90e-10 | 5 | 111 | 4 | 11346667 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 12010633 | ||
| Pubmed | Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis. | 4.90e-10 | 5 | 111 | 4 | 17626886 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 19359380 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 15316240 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 17301034 | ||
| Pubmed | Growth hormone action in the developing neural retina: a proteomic analysis. | 4.90e-10 | 5 | 111 | 4 | 18203262 | |
| Pubmed | Assignment of the porcine growth hormone gene to chromosome 12. | 4.90e-10 | 5 | 111 | 4 | 2249485 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 17242167 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 18180319 | ||
| Pubmed | Cloning and characterisation of the GH gene from the common dolphin (Delphinus delphis). | 4.90e-10 | 5 | 111 | 4 | 12225773 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 3780533 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 10395045 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 24190208 | ||
| Pubmed | Brief report: short stature caused by a mutant growth hormone. | 4.90e-10 | 5 | 111 | 4 | 8552145 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 36762426 | ||
| Pubmed | High molecular weight isoforms of growth hormone in cells of the immune system. | 4.90e-10 | 5 | 111 | 4 | 21741628 | |
| Pubmed | Structure of the growth hormone-encoding gene and its promoter in mice. | 4.90e-10 | 5 | 111 | 4 | 8647448 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 26887678 | ||
| Pubmed | The role of growth hormone in fetal mouse reproductive tract differentiation. | 4.90e-10 | 5 | 111 | 4 | 8756530 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 31099824 | ||
| Pubmed | Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. | 4.90e-10 | 5 | 111 | 4 | 1980158 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 17881271 | ||
| Pubmed | Neural growth hormone implicated in body weight sex differences. | 4.90e-10 | 5 | 111 | 4 | 23861378 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 12759574 | ||
| Pubmed | Growth hormone production and action in N1E-115 neuroblastoma cells. | 4.90e-10 | 5 | 111 | 4 | 19301152 | |
| Pubmed | Adipocyte insensitivity to insulin in growth hormone-transgenic mice. | 4.90e-10 | 5 | 111 | 4 | 11350075 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 18617616 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 11570960 | ||
| Pubmed | Promoter shuffling has occurred during the evolution of the vertebrate growth hormone gene. | 4.90e-10 | 5 | 111 | 4 | 10974531 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 23428905 | ||
| Pubmed | Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH. | 4.90e-10 | 5 | 111 | 4 | 17761891 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 12399427 | ||
| Pubmed | GH modulates hepatic epidermal growth factor signaling in the mouse. | 1.47e-09 | 6 | 111 | 4 | 20032199 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 11316754 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 23150490 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 2991252 | ||
| Pubmed | Third party data gene data set of eutherian growth hormone genes. | 1.47e-09 | 6 | 111 | 4 | 26697363 | |
| Pubmed | Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse. | 1.47e-09 | 6 | 111 | 4 | 15985453 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 20863500 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 12208853 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 9175714 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 16141391 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 18618017 | ||
| Pubmed | Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. | 1.47e-09 | 6 | 111 | 4 | 14759511 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 15166120 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 24691732 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 38951485 | ||
| Pubmed | Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion. | 1.47e-09 | 6 | 111 | 4 | 14530511 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 21849508 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 33368660 | ||
| Pubmed | Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. | 1.47e-09 | 6 | 111 | 4 | 14702113 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 9556071 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 8990189 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 12933669 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 22890843 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 15138153 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 30333823 | ||
| Pubmed | GH/STAT5 signaling during the growth period in livers of mice overexpressing GH. | 1.47e-09 | 6 | 111 | 4 | 25691498 | |
| Pubmed | The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. | 1.47e-09 | 6 | 111 | 4 | 23349524 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 26762506 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 25811804 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 19619004 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 14563698 | ||
| Interaction | CEP128 interactions | BICD2 HAUS6 RPGRIP1L CEP290 APC CCDC85C CEP350 ANKRD28 ASCC3 PIBF1 SIPA1L2 NIN | 8.17e-08 | 297 | 110 | 12 | int:CEP128 |
| Interaction | NDC80 interactions | BICD2 HAUS6 RPGRIP1L CEP290 CCDC85C CEP350 XPO5 SYNE2 ZW10 PIBF1 GOLGA2 NIN | 1.39e-07 | 312 | 110 | 12 | int:NDC80 |
| Interaction | CEP135 interactions | BICD2 HAUS6 RPGRIP1L CEP290 APC GTPBP1 CEP350 ANKRD28 PIBF1 SIPA1L2 NIN | 2.90e-07 | 272 | 110 | 11 | int:CEP135 |
| Interaction | PHF21A interactions | BICD2 HAUS6 APC CCDC85C RB1CC1 THAP11 ANAPC1 ANKRD28 ASCC3 GOLGA5 PKN3 TANGO6 | 3.85e-07 | 343 | 110 | 12 | int:PHF21A |
| Interaction | KRT18 interactions | BICD2 RPGRIP1L CEP290 APC RB1CC1 PRPF8 CEP350 XPO5 PIBF1 SIPA1L2 GOLGA2 TANGO6 NIN | 4.81e-07 | 419 | 110 | 13 | int:KRT18 |
| Interaction | NIN interactions | BICD2 HAUS6 RPGRIP1L TRIO CEP290 APC CCDC85C GTPBP1 CEP350 PIBF1 SIPA1L2 NIN | 6.25e-07 | 359 | 110 | 12 | int:NIN |
| Interaction | CNTRL interactions | HAUS6 RPGRIP1L NAA15 CCDC85C ARHGEF18 CEP350 ANKRD28 PIBF1 NIN | 1.14e-06 | 193 | 110 | 9 | int:CNTRL |
| Interaction | VPS33B interactions | 1.46e-06 | 199 | 110 | 9 | int:VPS33B | |
| Interaction | SASS6 interactions | 2.61e-06 | 159 | 110 | 8 | int:SASS6 | |
| Interaction | KDM1A interactions | BICD2 HAUS6 RPGRIP1L APC CCDC85C RB1CC1 CEP350 XPO5 MLC1 ANAPC1 ANKRD28 ASCC3 GOLGA5 GOLGA2 HTT TANGO6 SYMPK NIN | 3.26e-06 | 941 | 110 | 18 | int:KDM1A |
| Interaction | WHAMMP3 interactions | 4.03e-06 | 119 | 110 | 7 | int:WHAMMP3 | |
| Interaction | INSYN1 interactions | 4.11e-06 | 169 | 110 | 8 | int:INSYN1 | |
| Interaction | PCM1 interactions | BICD2 FILIP1 FAM184B HAUS6 RPGRIP1L CEP290 CCDC85C RB1CC1 CEP350 PIBF1 GOLGA2 NIN | 4.48e-06 | 434 | 110 | 12 | int:PCM1 |
| Interaction | CCHCR1 interactions | 4.63e-06 | 229 | 110 | 9 | int:CCHCR1 | |
| Interaction | KRT38 interactions | 4.68e-06 | 172 | 110 | 8 | int:KRT38 | |
| Interaction | DUSP16 interactions | 6.12e-06 | 237 | 110 | 9 | int:DUSP16 | |
| Interaction | GOLGA1 interactions | 7.38e-06 | 183 | 110 | 8 | int:GOLGA1 | |
| Interaction | GSK3A interactions | TRIO LRSAM1 APC ARHGEF12 PSMD8 ARHGEF11 STAT2 CEP350 ANKRD28 ASCC3 SIPA1L2 NIN | 8.80e-06 | 464 | 110 | 12 | int:GSK3A |
| Interaction | STIL interactions | 9.72e-06 | 190 | 110 | 8 | int:STIL | |
| Interaction | NCKAP5L interactions | 2.53e-05 | 106 | 110 | 6 | int:NCKAP5L | |
| Interaction | ODF2 interactions | 2.58e-05 | 158 | 110 | 7 | int:ODF2 | |
| Interaction | SSX2IP interactions | HAUS6 RPGRIP1L CEP290 CCDC85C CEP350 PIBF1 SIPA1L2 GOLGA2 NIN | 2.89e-05 | 288 | 110 | 9 | int:SSX2IP |
| Interaction | LATS1 interactions | MYH7 CEP290 APC CCDC85C PSMD8 CEP350 ANAPC1 ANKRD28 SIPA1L2 GOLGA2 NIN | 2.91e-05 | 440 | 110 | 11 | int:LATS1 |
| Interaction | HAUS6 interactions | 2.91e-05 | 161 | 110 | 7 | int:HAUS6 | |
| Interaction | RPGRIP1L interactions | 3.29e-05 | 225 | 110 | 8 | int:RPGRIP1L | |
| Interaction | MIB1 interactions | 3.48e-05 | 295 | 110 | 9 | int:MIB1 | |
| Interaction | PSMD9 interactions | 5.14e-05 | 176 | 110 | 7 | int:PSMD9 | |
| Interaction | RABGAP1L interactions | 5.84e-05 | 123 | 110 | 6 | int:RABGAP1L | |
| Interaction | CCDC138 interactions | 5.84e-05 | 123 | 110 | 6 | int:CCDC138 | |
| Interaction | LCA5 interactions | 6.39e-05 | 125 | 110 | 6 | int:LCA5 | |
| Interaction | CSH2 interactions | 6.86e-05 | 15 | 110 | 3 | int:CSH2 | |
| Interaction | PPP2CA interactions | PMS2 RPGRIP1L APC CEP350 INTS5 CEP78 ANAPC1 PIM1 GOLGA2 PKN3 HTT | 6.87e-05 | 484 | 110 | 11 | int:PPP2CA |
| Interaction | ENTR1 interactions | 7.79e-05 | 188 | 110 | 7 | int:ENTR1 | |
| Interaction | RCOR1 interactions | HAUS6 APC CCDC85C RB1CC1 THAP11 ANAPC1 ASCC3 GOLGA5 GOLGA2 PKN3 TANGO6 | 8.24e-05 | 494 | 110 | 11 | int:RCOR1 |
| Interaction | GH1 interactions | 8.41e-05 | 16 | 110 | 3 | int:GH1 | |
| Interaction | FAM178B interactions | 8.83e-05 | 3 | 110 | 2 | int:FAM178B | |
| Interaction | TRIM52 interactions | 9.01e-05 | 133 | 110 | 6 | int:TRIM52 | |
| Interaction | PXN interactions | 9.06e-05 | 334 | 110 | 9 | int:PXN | |
| Interaction | PFN1 interactions | TRIO APC ARHGEF12 ARHGEF11 STAT2 CEP350 SYNE2 ANKRD28 SIPA1L2 GOLGA2 HTT | 1.07e-04 | 509 | 110 | 11 | int:PFN1 |
| Interaction | PIBF1 interactions | 1.15e-04 | 200 | 110 | 7 | int:PIBF1 | |
| Interaction | CSH1 interactions | 1.22e-04 | 18 | 110 | 3 | int:CSH1 | |
| Interaction | TOP3B interactions | LPAR5 TRIO SZT2 TMEM94 DOCK9 SPTBN2 GTPBP1 ARHGEF11 KIFC2 ITPR2 THAP11 INTS5 MROH1 XPO5 MTHFR WDFY3 SIPA1L2 PKN3 HTT SYMPK | 1.24e-04 | 1470 | 110 | 20 | int:TOP3B |
| Interaction | KRT8 interactions | BICD2 RPGRIP1L APC ARHGEF12 PRPF8 CEP350 ANKRD28 PIBF1 SIPA1L2 NIN | 1.52e-04 | 441 | 110 | 10 | int:KRT8 |
| Interaction | KRT19 interactions | 1.59e-04 | 282 | 110 | 8 | int:KRT19 | |
| Interaction | GPR17 interactions | 1.63e-04 | 283 | 110 | 8 | int:GPR17 | |
| Interaction | H2BC9 interactions | BICD2 ADAMTS19 CEP290 ASH1L PRPF8 RFXAP CEP350 FSIP2 WDFY3 GOLGA2 | 1.66e-04 | 446 | 110 | 10 | int:H2BC9 |
| Interaction | POC5 interactions | 1.73e-04 | 95 | 110 | 5 | int:POC5 | |
| Interaction | NINL interactions | HAUS6 RPGRIP1L AKAP17A LRSAM1 CEP290 CCDC85C CEP350 PIBF1 SIPA1L2 HTT | 2.06e-04 | 458 | 110 | 10 | int:NINL |
| Interaction | KCNE3 interactions | 2.21e-04 | 296 | 110 | 8 | int:KCNE3 | |
| Interaction | CCDC93 interactions | 2.31e-04 | 101 | 110 | 5 | int:CCDC93 | |
| Interaction | TFPT interactions | 2.47e-04 | 160 | 110 | 6 | int:TFPT | |
| Interaction | HAUS3 interactions | 2.53e-04 | 103 | 110 | 5 | int:HAUS3 | |
| Interaction | HAUS4 interactions | 2.65e-04 | 104 | 110 | 5 | int:HAUS4 | |
| Interaction | YWHAZ interactions | RIPOR2 RPGRIP1L DOCK9 SPTBN2 BAG5 APC CCDC85C ARHGEF18 RB1CC1 PRPF8 FSIP2 SYNE2 ANKRD28 WDFY3 SIPA1L2 HTT ARHGAP19 NIN | 2.73e-04 | 1319 | 110 | 18 | int:YWHAZ |
| Interaction | APC interactions | 2.83e-04 | 389 | 110 | 9 | int:APC | |
| Interaction | CCDC126 interactions | 2.92e-04 | 5 | 110 | 2 | int:CCDC126 | |
| Interaction | CEP162 interactions | 3.21e-04 | 168 | 110 | 6 | int:CEP162 | |
| Interaction | PTK2 interactions | 3.36e-04 | 315 | 110 | 8 | int:PTK2 | |
| Interaction | GJA1 interactions | MYH7 TRIO APC HEATR5A ITPR2 SLC12A2 SYNE2 GOLGA5 SIPA1L2 GOLGA2 HTT | 3.46e-04 | 583 | 110 | 11 | int:GJA1 |
| Interaction | GPATCH1 interactions | 3.58e-04 | 111 | 110 | 5 | int:GPATCH1 | |
| Interaction | CDC14A interactions | 3.58e-04 | 111 | 110 | 5 | int:CDC14A | |
| Interaction | PCNT interactions | 3.59e-04 | 241 | 110 | 7 | int:PCNT | |
| Interaction | CIAO2A interactions | 3.76e-04 | 173 | 110 | 6 | int:CIAO2A | |
| Interaction | ZUP1 interactions | 3.88e-04 | 174 | 110 | 6 | int:ZUP1 | |
| Interaction | CEP170P1 interactions | 3.89e-04 | 113 | 110 | 5 | int:CEP170P1 | |
| Interaction | SYCE3 interactions | 3.91e-04 | 63 | 110 | 4 | int:SYCE3 | |
| Interaction | TUFT1 interactions | 3.91e-04 | 63 | 110 | 4 | int:TUFT1 | |
| Interaction | DCTN1 interactions | 3.94e-04 | 497 | 110 | 10 | int:DCTN1 | |
| Interaction | ARHGAP45 interactions | 4.21e-04 | 27 | 110 | 3 | int:ARHGAP45 | |
| Interaction | HERC2 interactions | BICD2 AKAP17A CCDC186 CEP290 ARHGEF12 RB1CC1 ITPR2 FARP2 SYNE2 NIN | 4.33e-04 | 503 | 110 | 10 | int:HERC2 |
| Interaction | PNMA2 interactions | 4.58e-04 | 251 | 110 | 7 | int:PNMA2 | |
| Interaction | B4GALT2 interactions | 4.93e-04 | 119 | 110 | 5 | int:B4GALT2 | |
| Interaction | HAUS1 interactions | 5.07e-04 | 183 | 110 | 6 | int:HAUS1 | |
| Interaction | FAM230I interactions | 5.21e-04 | 29 | 110 | 3 | int:FAM230I | |
| Interaction | DISC1 interactions | 5.76e-04 | 429 | 110 | 9 | int:DISC1 | |
| Interaction | AGBL4 interactions | 5.84e-04 | 70 | 110 | 4 | int:AGBL4 | |
| Interaction | CSHL1 interactions | 6.09e-04 | 7 | 110 | 2 | int:CSHL1 | |
| Interaction | CEP43 interactions | 6.17e-04 | 190 | 110 | 6 | int:CEP43 | |
| Interaction | SPICE1 interactions | 6.34e-04 | 191 | 110 | 6 | int:SPICE1 | |
| Interaction | OFD1 interactions | 6.36e-04 | 347 | 110 | 8 | int:OFD1 | |
| Interaction | FTL interactions | 6.48e-04 | 348 | 110 | 8 | int:FTL | |
| Interaction | FAM184A interactions | 6.50e-04 | 72 | 110 | 4 | int:FAM184A | |
| Interaction | CEP192 interactions | 6.52e-04 | 192 | 110 | 6 | int:CEP192 | |
| Interaction | GRIPAP1 interactions | 6.52e-04 | 192 | 110 | 6 | int:GRIPAP1 | |
| Interaction | MZT2B interactions | 7.21e-04 | 74 | 110 | 4 | int:MZT2B | |
| Cytoband | 17q24.2 | 8.45e-07 | 30 | 111 | 4 | 17q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 2.14e-04 | 120 | 111 | 4 | chr17q23 | |
| Cytoband | 5q23.3 | 5.17e-04 | 14 | 111 | 2 | 5q23.3 | |
| GeneFamily | Growth hormone family | 2.90e-09 | 6 | 69 | 4 | 1175 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.88e-07 | 66 | 69 | 6 | 722 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.37e-04 | 181 | 69 | 5 | 694 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 9.24e-04 | 12 | 69 | 2 | 660 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.14e-03 | 206 | 69 | 5 | 682 | |
| GeneFamily | AAA ATPases|Peroxins | 1.66e-03 | 16 | 69 | 2 | 957 | |
| Coexpression | HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN | 4.18e-06 | 57 | 110 | 5 | MM807 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_1_DN | 7.44e-06 | 64 | 110 | 5 | M2237 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.09e-07 | 200 | 111 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.09e-07 | 200 | 111 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.09e-07 | 200 | 111 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.63e-06 | 183 | 111 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 191 | 111 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 191 | 111 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-06 | 194 | 111 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.04e-05 | 198 | 111 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.07e-05 | 199 | 111 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.07e-05 | 199 | 111 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.07e-05 | 199 | 111 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 199 | 111 | 6 | f197ab861767ee06aa47b86c537fb3d8c2b2bc3e | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.49e-05 | 138 | 111 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-pDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.96e-05 | 152 | 111 | 5 | 0c6dd41142e4ca1e54ca41e05e42ed29fbf0e570 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 158 | 111 | 5 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 158 | 111 | 5 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 163 | 111 | 5 | 7a04192710f55acf5a4681d5f09942358fdb02ff | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.55e-05 | 169 | 111 | 5 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-05 | 175 | 111 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.93e-05 | 176 | 111 | 5 | 6b06da40eb97ea2db09f3a769494738b3e5fe3fa | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.93e-05 | 176 | 111 | 5 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 178 | 111 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_C|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.37e-05 | 178 | 111 | 5 | 7203149864cc8d5ae25329fdbf15c6b73c3d3595 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 179 | 111 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.05e-05 | 181 | 111 | 5 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.05e-05 | 181 | 111 | 5 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.05e-05 | 181 | 111 | 5 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 186 | 111 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.05e-04 | 187 | 111 | 5 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 189 | 111 | 5 | 7dad62bd50c197838058e89abd0ee387de3e83cd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 191 | 111 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 191 | 111 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 192 | 111 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-04 | 194 | 111 | 5 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | COVID-19-lung-NK_cells|lung / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 195 | 111 | 5 | 3b716ec7acc9a37af6bf40e711a539ce58d74aa4 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(4)_1wkpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.29e-04 | 103 | 111 | 4 | 942cc6f9699f777638e59aee40a402a16fdbb2e7 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 196 | 111 | 5 | b6cc1f466d45479764080d34b1daeb8243a5a9f3 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 196 | 111 | 5 | ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 196 | 111 | 5 | 039044ab28c53391c34d8226fb8cf78549e63ef4 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.31e-04 | 196 | 111 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Neuronal-GABAergic_neurons|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-04 | 197 | 111 | 5 | e1a80c1aa7f7e83f5d19a40fe37db5c5a6c25685 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.35e-04 | 197 | 111 | 5 | 8fa38fb95e285f9cc756ec4f32009be4ede09d3c | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.35e-04 | 197 | 111 | 5 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.38e-04 | 198 | 111 | 5 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.38e-04 | 198 | 111 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.38e-04 | 198 | 111 | 5 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.38e-04 | 198 | 111 | 5 | 436f3a9ef31b0991765bb97c21960f20fa71d578 | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 1.38e-04 | 198 | 111 | 5 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.41e-04 | 199 | 111 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.41e-04 | 199 | 111 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 1.41e-04 | 199 | 111 | 5 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | 5.21e-06 | 195 | 111 | 8 | 5109_DN | |
| Drug | Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 5.62e-06 | 197 | 111 | 8 | 5100_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; PC3; HT_HG-U133A | 5.83e-06 | 198 | 111 | 8 | 3755_UP | |
| Drug | SureCN160413 | 4.27e-05 | 40 | 111 | 4 | CID011446521 | |
| Drug | C-S-S | 4.52e-05 | 80 | 111 | 5 | CID000165331 | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 4.55e-05 | 193 | 111 | 7 | 950_UP | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | 4.86e-05 | 195 | 111 | 7 | 3735_DN | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; HL60; HT_HG-U133A | 4.86e-05 | 195 | 111 | 7 | 2409_DN | |
| Drug | 3'dGTP | 4.92e-05 | 15 | 111 | 3 | CID000148770 | |
| Drug | NS-398; Up 200; 10uM; MCF7; HT_HG-U133A | 5.02e-05 | 196 | 111 | 7 | 6911_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 5.02e-05 | 196 | 111 | 7 | 4844_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 3886_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 3723_DN | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 3865_DN | |
| Drug | Tyloxapol [25301-02-4]; Up 200; 4uM; PC3; HT_HG-U133A | 5.36e-05 | 198 | 111 | 7 | 4611_UP | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 5.36e-05 | 198 | 111 | 7 | 3436_UP | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 5.71e-05 | 200 | 111 | 7 | 4837_UP | |
| Drug | galactosone | 6.03e-05 | 16 | 111 | 3 | CID000097398 | |
| Drug | AC1L2Z50 | 6.03e-05 | 16 | 111 | 3 | CID000131414 | |
| Drug | beta-carene | 7.04e-05 | 3 | 111 | 2 | CID000011129 | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 9.46e-10 | 5 | 111 | 4 | DOID:0060872 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 6.58e-09 | 7 | 111 | 4 | DOID:0060870 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 1.84e-07 | 14 | 111 | 4 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | osteoporosis (biomarker_via_orthology) | 1.32e-06 | 22 | 111 | 4 | DOID:11476 (biomarker_via_orthology) | |
| Disease | Developmental delay (disorder) | 1.14e-05 | 37 | 111 | 4 | C0424605 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 1.41e-05 | 39 | 111 | 4 | DOID:9744 (implicated_via_orthology) | |
| Disease | Turcot syndrome (disorder) | 1.39e-04 | 5 | 111 | 2 | C0265325 | |
| Disease | Global developmental delay | 1.51e-04 | 133 | 111 | 5 | C0557874 | |
| Disease | Zellweger syndrome (implicated_via_orthology) | 2.08e-04 | 6 | 111 | 2 | DOID:905 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.91e-04 | 7 | 111 | 2 | C0751337 | |
| Disease | Intellectual Disability | 2.95e-04 | 447 | 111 | 8 | C3714756 | |
| Disease | Cardiovascular Diseases | 3.38e-04 | 36 | 111 | 3 | C0007222 | |
| Disease | Lynch Syndrome | 4.96e-04 | 9 | 111 | 2 | C4552100 | |
| Disease | atrial fibrillation | 5.20e-04 | 371 | 111 | 7 | EFO_0000275 | |
| Disease | Meckel-Gruber syndrome | 6.19e-04 | 10 | 111 | 2 | cv:C0265215 | |
| Disease | Russell-Silver syndrome | 6.19e-04 | 10 | 111 | 2 | C0175693 | |
| Disease | sexual dysfunction | 7.54e-04 | 11 | 111 | 2 | EFO_0004714 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 8.42e-04 | 49 | 111 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Infantile Refsum Disease (disorder) | 1.06e-03 | 13 | 111 | 2 | C0282527 | |
| Disease | anemia (is_implicated_in) | 1.24e-03 | 14 | 111 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | Meckel-Gruber syndrome | 1.43e-03 | 15 | 111 | 2 | C0265215 | |
| Disease | Replication Error Phenotype | 1.43e-03 | 15 | 111 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 1.43e-03 | 15 | 111 | 2 | C0920269 | |
| Disease | Peroxisome biogenesis disorders | 1.43e-03 | 15 | 111 | 2 | C1832200 | |
| Disease | Adrenoleukodystrophy, Neonatal | 1.43e-03 | 15 | 111 | 2 | C0282525 | |
| Disease | Zellweger Syndrome | 1.63e-03 | 16 | 111 | 2 | C0043459 | |
| Disease | Meckel syndrome type 1 | 2.06e-03 | 18 | 111 | 2 | C3714506 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.34e-03 | 147 | 111 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Familial aplasia of the vermis | 2.55e-03 | 20 | 111 | 2 | cv:C0431399 | |
| Disease | calcium measurement | 2.61e-03 | 628 | 111 | 8 | EFO_0004838 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.64e-03 | 152 | 111 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | parental longevity | 2.69e-03 | 494 | 111 | 7 | EFO_0007796 | |
| Disease | PR interval | 2.72e-03 | 495 | 111 | 7 | EFO_0004462 | |
| Disease | asthma, endometriosis | 2.77e-03 | 74 | 111 | 3 | EFO_0001065, MONDO_0004979 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 3.08e-03 | 22 | 111 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | transitional cell carcinoma (is_implicated_in) | 3.08e-03 | 22 | 111 | 2 | DOID:2671 (is_implicated_in) | |
| Disease | Etat Marbre | 3.37e-03 | 23 | 111 | 2 | C0266487 | |
| Disease | Huntington's disease (is_implicated_in) | 3.37e-03 | 23 | 111 | 2 | DOID:12858 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LELSLEINRKLQAVL | 846 | Q7Z3E2 | |
| ILLTDVLLLLQEKDQ | 706 | Q6ZSZ5 | |
| RERLNQILLNLLEKI | 2921 | Q9NR48 | |
| LLLEKNLKRLLQLER | 191 | Q8IYX3 | |
| IRLEELLTKQLLALD | 396 | Q9UL15 | |
| IQQKLALTQRLELLE | 786 | Q8TD16 | |
| QIQIIILVLVRALKS | 226 | Q96P56 | |
| IDELDILRLKLENNI | 891 | Q86UK0 | |
| NILQETLKLLQRLLK | 316 | O00178 | |
| EQLVLKRVANILINL | 526 | Q9H845 | |
| VLLLEDLLVLLQKQD | 986 | O15085 | |
| ALLILEKITDRNLIN | 906 | O15084 | |
| VLKNLELNGLILRER | 121 | Q5JTW2 | |
| QEKLQLLLEELRGEL | 81 | Q9Y592 | |
| ELLQLLLELLGRAKV | 4166 | Q96M86 | |
| EKLNDIQLALVIARL | 1716 | Q9Y485 | |
| KLVDVLQLLQRLRDL | 516 | Q9HA90 | |
| LLLEDILVLLQKQDD | 1041 | Q9NZN5 | |
| ILVLLQKQDDRLVLR | 1046 | Q9NZN5 | |
| LSVQVNLRVIKLILL | 366 | Q8TE59 | |
| LVRLVLLRLVDENLL | 301 | P35557 | |
| LKIIEILQFILSVRL | 971 | Q14571 | |
| LLRLQDLVDKLQLKV | 1861 | P12883 | |
| LVELLVQLARDLKLG | 786 | Q9H1A4 | |
| GEKLQALLRLVIELL | 466 | Q8TDY2 | |
| LLKEELLRVNRQGIL | 466 | P42898 | |
| FRELRILILDKNLLK | 371 | A4D1F6 | |
| QNRLLILILSIIFIK | 996 | O60732 | |
| KTVRLLLANLVIFLL | 231 | Q9H1C0 | |
| EVLIKELAEGLLLQI | 311 | Q9NPP4 | |
| LRRKENEIELSLLQL | 236 | Q68CZ1 | |
| LAVLLDNILQRIGKL | 86 | Q09328 | |
| IRSQIKLIETELLQL | 471 | Q6UWE0 | |
| LAVLKVRLQEADQLL | 301 | Q8TBA6 | |
| LIQLRDILKSALQVE | 266 | O43150 | |
| LDALLVLAELILDLK | 111 | Q96D96 | |
| LNVKLQNSLLEVLRL | 486 | Q9ULE4 | |
| LLAEVINIIKREDLL | 391 | P80404 | |
| ALLRENLELKELVLL | 136 | A6NKD9 | |
| KSNLELLRISLLLIE | 96 | P0DML3 | |
| FLLNVVCEKLIRILL | 3751 | Q5CZC0 | |
| KDNLQILRDLSLLQI | 111 | Q6N069 | |
| SIRQLQLLLLKVALL | 156 | Q8TDZ2 | |
| QRQVLILLLLLEVTL | 11 | Q9Y5E8 | |
| VDLDQLIAALQILLK | 1606 | Q8NDA8 | |
| CLKQILLLQLDLIEQ | 221 | Q68DK7 | |
| KLLELQELVLRLVGD | 881 | Q08379 | |
| LSLIEKRLVELLTVQ | 411 | Q96M63 | |
| KDNLQILRDLSLLQI | 111 | Q9BXJ9 | |
| ILVLKQFLLQRDLNE | 361 | Q5XG87 | |
| LREQLGKIRLELLTI | 436 | P0CG20 | |
| LALSANILILIIINK | 46 | Q8NGI1 | |
| IGLLKVLIIRQVILQ | 696 | P26012 | |
| ALDLRKRQVLIFLVL | 6 | Q9Y5E9 | |
| LELLVQPKLLARELL | 71 | Q9Y2L6 | |
| KQVLDLLAQLVQLRV | 1446 | P42858 | |
| TQRLLILEQLLDSIK | 796 | Q86XA9 | |
| EVRLIAISVLKNLLI | 1131 | Q9BZ29 | |
| AIAIVQLQELSLRLK | 106 | P09603 | |
| IAVLLDDILQRLVKL | 86 | Q96EE4 | |
| IEELRLQELKLNREL | 1351 | O15078 | |
| KVSLLRQLELLRELN | 331 | Q8N4Y2 | |
| LLLRLQQEKAEIKRL | 1746 | Q5VT06 | |
| LKEIRNILLKQQELL | 801 | P10911 | |
| KLNLLTVIQLLNEVL | 301 | Q7Z4H7 | |
| ILIRLENLQKLTELQ | 726 | O94887 | |
| KSNLELLRISLLLIE | 96 | P0DML2 | |
| LALKLRLQVLLLARV | 186 | O96011 | |
| LLKDLLRQELRQLLQ | 76 | Q8N4L8 | |
| QLREALKILAERVLI | 366 | Q96A83 | |
| QRLEQLILGQLEELK | 196 | Q96AC6 | |
| KQLESQLQRLRELLL | 861 | Q13474 | |
| SQKLDLLRLALEQLL | 226 | Q6P5Z2 | |
| LIREIALILINVVLD | 191 | Q8NHC5 | |
| LLVLLNDGILRKELR | 56 | Q9Y5Y5 | |
| ENILIDLNRGELKLI | 171 | P11309 | |
| RQRLLLLEVVDKKLQ | 2646 | Q5T011 | |
| LLLEEKRILIQAQRA | 111 | P52630 | |
| VEKQQLLLTLLLQRI | 3521 | Q8WXH0 | |
| LRLKLVGLTQRIEEL | 331 | Q7Z7B0 | |
| LNVLVLRLQGKIEKL | 1321 | Q8N4C6 | |
| LPKVDLQQLLLLLLE | 466 | Q8IXR5 | |
| LELILRQLQTDLRKE | 1661 | Q9P2F8 | |
| LLEQVLNQKRLSLLR | 226 | O00287 | |
| LLLLIIALQRLKNII | 56 | A2A2V5 | |
| DRLIQLLLLHLQKLV | 436 | Q6P9B9 | |
| LLAQQEVLRTLALLL | 936 | Q9Y4F9 | |
| ALLRLVVELVQELRK | 36 | Q6UX46 | |
| IKLEERKLLLAQRNL | 356 | Q02040 | |
| IQQIEKDILRIRQLL | 221 | P25054 | |
| GLELIEKLLQNRITI | 276 | Q8N3C0 | |
| EKIDLTLLNRLLRLI | 986 | Q6P2Q9 | |
| KSNLELLRISLLLIQ | 96 | P01242 | |
| ILLRNRLLDILLKLI | 1631 | Q8IZQ1 | |
| RLLLNLELQKVFQDL | 526 | O15020 | |
| LILLEQILQKTREVQ | 56 | Q8WYR1 | |
| LLLNLVLIGRQDRLK | 106 | Q12767 | |
| EAKAQIVLLVILLLA | 431 | P55011 | |
| KQLTIQVLLDRLVLR | 446 | Q9H269 | |
| IERKELLHNIQLLKI | 51 | Q8WXW3 | |
| TEQILKLLDNLLALI | 766 | Q9HAV4 | |
| TLLVEGQERKLLVLQ | 631 | Q9C0B7 | |
| KSNLELLRISLLLIQ | 96 | P01241 | |
| KDRQIEALQLLFLIL | 221 | Q14CB8 | |
| QILILFNIILISKLL | 11 | Q9NYK1 | |
| KRDIELLLKLIANLN | 101 | Q92797 | |
| RQILLQEEKLLLAVL | 341 | P54278 | |
| LTKQQLILARDILEI | 136 | P48556 | |
| LALLRLKEVLQRLQE | 836 | Q6BDS2 | |
| ELLRKLNEQRDILAL | 256 | Q96EK4 | |
| QERKIKLELFLQLRI | 776 | O75962 | |
| IRLVLEVLQKQLLDL | 296 | O43264 | |
| NINFNLILLLLLELL | 141 | Q15049 | |
| LQQKQLLILQLLEKI | 381 | P0CAP1 |